文献速递血液净化与透析

腹膜透析模式与结局:PDOPPS研究分析

Peritoneal Dialysis Modality and Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
PubMed 文献 · Kidney Int Rep · 2026-06-18

基于PDOPPS多国队列9463例新入腹膜透析患者,采用意向性治疗Cox回归比较自动腹膜透析(APD)与持续不卧床腹膜透析(CAPD)的结局。APD与CAPD在患者生存和永久转血液透析上无显著差异,但APD总体腹膜炎风险较低,尤其革兰阳性及培养阴性腹膜炎。

要点

  • APD与CAPD患者生存和转HD风险无显著差异。
  • APD腹膜炎风险较低,尤其革兰阳性和培养阴性。
  • 辅助腹膜透析患者中APD死亡风险较低。

核心结论

  • APD与CAPD患者生存和技术生存相当。
  • APD腹膜炎发生率较低,提示无菌操作的重要性。
  • APD在需辅助的腹膜透析患者中可能更适合。

研究设计与样本

  • PDOPPS多国前瞻性队列研究,纳入6个国家/地区9463例开始腹膜透析3个月内患者。
  • 采用意向性治疗Cox回归模型,调整患者和机构因素并按国家分层。

主要发现

  • 87%患者处方APD(范围:韩国37%至美国91%)。
  • APD患者更年轻、尿量更低、更常用高渗溶液、较少使用艾考糊精。
  • APD与CAPD生存无显著差异(AHR 0.82,95%CI 0.66-1.03)。
  • APD与CAPD永久转HD无显著差异(AHR 0.96,95%CI 0.83-1.11)。
  • APD总体腹膜炎风险较低(AHR 0.83,95%CI 0.72-0.97),革兰阳性(AHR 0.67,95%CI 0.52-0.87)和培养阴性(AHR 0.64,95%CI 0.44-0.95)腹膜炎风险亦较低。

临床怎么用

  • 选择APD或CAPD时无需担心生存或技术生存差异。
  • APD可能降低腹膜炎风险,应强调无菌操作。
  • 对需辅助的腹膜透析患者,APD可能是合适选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Automated peritoneal dialysis (APD) is the predominant peritoneal dialysis (PD) modality in many high-income countries and is increasingly adopted in low- and middle-income settings. Outcome differences between APD and continuous ambulatory PD (CAPD) remain unclear. A clearer understanding could inform clinical and policy decisions. METHODS: Patients in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS; N = 9463 patients across 6 countries/regions) who were enrolled within 3 months of starting PD were analyzed in intent-to-treat Cox regression models examining associations between PD modality (CAPD vs. APD) and patient survival, permanent transfer to hemodialysis (HD, HDT), and time to first peritonitis, adjusting for patient and facility-level factors and stratified by country. RESULTS: Of the patients, 87% were prescribed APD (range: 37% in South Korea to 91% in USA). APD patients were younger, had lower urine output, more often used hypertonic solutions, and less often used icodextrin. Overall, there was no evident difference between APD and CAPD in survival (adjusted hazard ratio [AHR]: 0.82, 95% confidence interval [CI]: 0.66-1.03) or HDT (AHR: 0.96, 95% CI: 0.83-1.11), though results varied by country and subgroups (APD had lower death risk in those having assisted PD). APD patients had a lower risk of peritonitis overall (AHR: 0.83, 95% CI: 0.72-0.97), and specifically of gram-positive (AHR: 0.67, 95% CI: 0.52-0.87) and culture-negative (AHR: 0.64, 95% CI: 0.44-0.95) peritonitis. CONCLUSION: APD and CAPD showed comparable patient and technique survival. APD's lower peritonitis rate highlights the importance of aseptic technique; its benefits in assisted PD patients suggest that it may be suited for those requiring support.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. de Moraes T, Bieber B, Zhao J, et al. Peritoneal Dialysis Modality and Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Kidney Int Rep. 2026. PMID: 42540249. doi:10.1016/j.ekir.2026.106664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。